Correlation Between BriaCell Therapeutics and TC BioPharm

Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BriaCell Therapeutics Corp and TC BioPharm Holdings, you can compare the effects of market volatilities on BriaCell Therapeutics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and TC BioPharm.

Diversification Opportunities for BriaCell Therapeutics and TC BioPharm

-0.34

Correlation Coefficient

BriaCell Therapeutics  TC BioPharm

Very good diversification

The 3 months correlation between BriaCell and TCBP is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and TC BioPharm go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and TC BioPharm

Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to generate 0.99 times more return on investment than TC BioPharm. However, BriaCell Therapeutics Corp is 1.01 times less risky than TC BioPharm. It trades about 0.16 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.27 per unit of risk. If you would invest  21.00  in BriaCell Therapeutics Corp on September 2, 2024 and sell it today you would earn a total of  22.00  from holding BriaCell Therapeutics Corp or generate 104.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

BriaCell Therapeutics Corp  vs.  TC BioPharm Holdings

BriaCell Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

TC BioPharm Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with BriaCell Therapeutics and TC BioPharm

The main advantage of trading using opposite BriaCell Therapeutics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.

The idea behind BriaCell Therapeutics Corp and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.